CIK 0002070849 · Non-accelerated filer<br>Emerging growth company
BillionToOne, Inc.
Sign in to watch- Ticker
- BLLN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811082020
- Phone
- 650-460-2551
- Business address
- 1035 O'BRIEN DRIVE, MENLO PARK, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,737,121
- in 19 filings, $26.7M under 10b5-1 plans
Net −$26,737,121. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-07 | Tsao David Chief Technology Officer | Other acquisition · Class B Common Stock | +2,325,108 | 2,325,108 | ||
| 2025-11-07 | Tsao David Chief Technology Officer | Other disposition · Stock Option (right to buy) | −640,000 | 0 | ||
| 2025-11-07 | Tsao David Chief Technology Officer | Other acquisition · Stock Option (right to buy) | +640,000 | 640,000 | ||
| 2025-11-07 | Tsao David Chief Technology Officer | Other disposition · Stock Option (right to buy) | −501,551 | 0 | ||
| 2025-11-07 | Tsao David Chief Technology Officer | Other acquisition · Stock Option (right to buy) | +501,551 | 501,551 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other disposition | −220,000 | 0 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other acquisition | +220,000 | 220,000 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other disposition · Stock Option (right to buy) | −50,000 | 0 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other acquisition · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other disposition · Stock Option (right to buy) | −40,000 | 0 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other acquisition · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other disposition · Stock Option (right to buy) | −65,000 | 0 | ||
| 2025-11-07 | Sakakibara Shan Riku Chief Product Officer | Other acquisition · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2025-11-07 | Taylor Ross Chief Financial Officer | Other disposition · Stock Option (right to buy) | −175,000 | 0 | ||
| 2025-11-07 | Taylor Ross Chief Financial Officer | Other acquisition · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2025-11-07 | Taylor Ross Chief Financial Officer | Other disposition · Stock Option (right to buy) | −75,000 | 0 | ||
| 2025-11-07 | Taylor Ross Chief Financial Officer | Other acquisition · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2025-11-07 | ten Bosch John Roderick See Remarks | Other disposition | −37,000 | 0 | ||
| 2025-11-07 | ten Bosch John Roderick See Remarks | Other acquisition | +37,000 | 37,000 | ||
| 2025-11-07 | ten Bosch John Roderick See Remarks | Purchase | +800 | $60.00 | $48K | 37,800 |
Page 24 of 32 · 639 trades